IL-18 binding proteins
    6.
    发明专利

    公开(公告)号:AU2011224023B2

    公开(公告)日:2012-09-13

    申请号:AU2011224023

    申请日:2011-09-13

    Applicant: ABBOTT LAB

    Abstract: IL -18 BINDING PRO TEINS Abstract The present invention encompasses IL-1 8 binding proteins, particularly antibodies that bind human interleukin- 18 (hIL- 18). Specifically, the invention relates to antibodies that are entirely human antibodies. Preferred antibodies have high affinity for hlL-18 and/or that neutralize hIL-1 8 activity in vitro and in vivo. An antibody of the io invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hlL- 18 and for inhibiting hIL-18 activity, e.g., in a human subject suffering from a disorder in which hlL 18 activity is detrimental.

    8.
    发明专利
    未知

    公开(公告)号:AT555130T

    公开(公告)日:2012-05-15

    申请号:AT04817825

    申请日:2004-11-12

    Applicant: ABBOTT LAB

    Abstract: The present invention encompasses IL-18 binding proteins, particularly antibodies that bind human interleukin-18 (hIL-18). Specifically, the invention relates to antibodies that are entirely human antibodies. Preferred antibodies have high affinity for hIL-18 and/or that neutralize hIL-18 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hIL-18 and for inhibiting hIL-18 activity, e.g., in a human subject suffering from a disorder in which hIL-18 activity is detrimental.

    9.
    发明专利
    未知

    公开(公告)号:BRPI0416255A

    公开(公告)日:2007-01-09

    申请号:BRPI0416255

    申请日:2004-11-12

    Applicant: ABBOTT LAB

    Abstract: The present invention encompasses IL-18 binding proteins, particularly antibodies that bind human interleukin-18 (hIL-18). Specifically, the invention relates to antibodies that are entirely human antibodies. Preferred antibodies have high affinity for hIL-18 and/or that neutralize hIL-18 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hIL-18 and for inhibiting hIL-18 activity, e.g., in a human subject suffering from a disorder in which hIL-18 activity is detrimental.

Patent Agency Ranking